NeuroOne Medical Technologies Corporation (NMTC) Operating income 2016–2025
NeuroOne Medical Technologies Corporation (NMTC) annual operating income history from SEC filings — each fiscal year as reported.
-$4.2MFY2025 · since FY2016: -$32,611 → -$4.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.2M | +64.4% |
| FY2024 | -$11.9M | +0.6% |
| FY2023 | -$12.0M | -19.2% |
| FY2022 | -$10.0M | +1.8% |
| FY2021 | -$10.2M | -108.4% |
| FY2020 | -$4.9M | +15.7% |
| FY2019 | -$5.8M | — |
| FY2017 | -$3.1M | -9321.1% |
| FY2016 | -$32,611 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NMTC financial trends
NMTC RevenueNMTC Net incomeNMTC Net marginNMTC Gross profitNMTC Gross marginNMTC Operating marginNMTC Operating cash flowNMTC Free cash flowNMTC Capital expendituresNMTC Return on equityNMTC Stock buybacksNMTC Dividends paidNMTC Total assetsNMTC Total liabilitiesNMTC Shareholders’ equityNMTC overview →